Tomohiro Watanabe
Scientist Ajinomoto Co., Inc.
Seminars
Wednesday 14th October 2026
Unlocking Next-Generation Antibody-Based Conjugates through AJICAP Site-Specific Conjugation & Linker Technologies
8:30 am
- AJICAP Conjugation: Exploring site-specific chemical conjugation technology enabling precise DAR control, including DAR1 conjugates, in next-generation ADCs
- AJICAP Linker: Demonstrating a novel hydrophilic linker technology that enhances stability and versatile synthesis of ADCs with higher DAR
- Evaluating AJICAP-derived ADCs exhibiting high in vivo stability in NHP studies, supporting suitability for further development
- Beyond Conventional ADCs: Exploring site-specific conjugation of bispecific antibodies and AOCs with biological evaluation
